Belarus vs Iran: Trading across borders: Cost to export: Documentary compliance (USD) (

Belarus
85
in 2019
Iran
85
in 2019
Belarus rank
65th
Iran rank
65th

Trading across borders: Cost to export: Documentary compliance (USD) ( over time

  • Belarus
  • Iran
020406080201420162019

How they compare

Belarus currently reports 85 against 85 in Iran, a difference of 0.

The two have swapped places 1 time across 6 shared years of data; in 2014 it was Belarus ahead.

Belarus ranks 65th and Iran ranks 65th of 188 countries.

Belarus has averaged higher in every one of the 1 decades both report.

Frequently asked questions

Which has higher trading across borders: cost to export: documentary compliance (usd) (, Belarus or Iran?
Belarus, at 85 against 85 in Iran as of 2019.
What is the difference in trading across borders: cost to export: documentary compliance (usd) ( between Belarus and Iran?
0, with Belarus ahead.
How many years of comparable data are there for Belarus and Iran?
6 years are reported by both, from 2014 to 2019.
How do Belarus and Iran rank globally for trading across borders: cost to export: documentary compliance (usd) (?
Belarus ranks 65th and Iran ranks 65th of 188 countries.
Where does this data come from?
The World Bank, published as Trading across borders: Cost to export: Documentary compliance (USD) (DB16-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Trading across borders: Cost to export: Documentary compliance (USD) (DB16-20 methodology) - Score
Source
World Bank
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
190 places, 1,139 data points, 2014–2019
Last refreshed

The score for the cost for documentary compliance to export benchmarks economies with respect to the regulatory best practice on the indicator. The score ranges from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB16-20 studies.